Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Filing Names

Bayer Schering Pharma Aktiengesellschaft
Bayer Schering Pharma Aktiengesellschaft_20100121
Bayer Schering Pharma Aktiengesellschaft_20100128

Bayer Schering Pharma Aktiengesellschaft patents

Recent patent applications related to Bayer Schering Pharma Aktiengesellschaft. Bayer Schering Pharma Aktiengesellschaft is listed as an Agent/Assignee. Note: Bayer Schering Pharma Aktiengesellschaft may have other listings under different names/spellings. We're not affiliated with Bayer Schering Pharma Aktiengesellschaft, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | Bayer Schering Pharma Aktiengesellschaft-related inventors

Date Bayer Schering Pharma Aktiengesellschaft patents (updated weekly) - BOOKMARK this page
10/09/14[f-18]-labeled l-glutamic acid, [f-18]-labeled l-glutamine, derivatives thereof and use thereof and processes for their preparation
09/11/14Hydroxymethylaryl-substituted pyrrolotriazines as alk1 inhibitors
08/14/14L-glutamic acid and l-glutamine derivative (iii), use thereof and obtaining them
08/01/13Heterocyclically substituted aryl compounds as hif inhibitors
03/07/132-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
11/08/12Drug delivery system
05/17/12Prodrugs and the use thereof
03/08/12Cartridge, medicament dispenser for solid medicament portions, and uses of the cartridge and of the medicament dispenser
02/09/12Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin ii antagonist and/or a diuretic
02/09/12Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof
02/02/12Substituted heterocyclylbenzylpyrazoles and use thereof
02/02/12Benzimidazole and pyrazolopyridine derivatives for treating and/or preventing cardiovascular diseases
01/26/12Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
01/26/12Substituted 5-fluoro-1h-pyrazolopyridines and their use
01/12/12Treatment of bacterial diseases of the respiratory organs
01/12/12Modification i of 4-(phenyl)ethyl]-amino}methyl)benzoic acid
01/05/12Use of helium-oxygen gas mixtures for treating pulmonary arterial hypertension
01/05/12Triazolo and tetrazolo pyrimidine derivatives as hne inhibitors for treating copd
12/22/11Aryl compounds with aminoalkyl substituents and their use
12/15/11Method for synthesis of a radionuclide-labeled compound using an exchange resin
12/08/11Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof
12/08/11Heteroaromatic compounds for use as hif inhibitors
12/01/11Pharmaceutical dispenser and use thereof
12/01/11Progestin-containing drug delivery system
12/01/11Dipeptoid prodrugs and the use thereof
12/01/11Sulfoximine-substituted anilinopyrimidine derivatives as cdk inhibitors, the production thereof, and use as medicine
11/24/11Cartridge, a pharmaceutical dispenser containing the cartridge, and applications of said cartridge and said pharmaceutical dispenser
11/24/11Monohydrate of 4-(phenyl)ethyl]-amino}methyl)benzoic acid
11/10/11Very low-dosed solid oral dosage forms for hrt
10/27/11Diaryl ureas for treating heart failure
10/27/11Antibodies which bind selectively to hair of animals and an antibody based drug delivery system for animals
10/20/11Graphical user interface
10/13/11Piperazine derivatives for binding and imaging amyloid plaques and their use
10/13/11Use of substituted 2, 3-dihydroimidazo[1,2-c]quinazolines for the treatment of myeloma
10/13/11Sulfone-substituted anilinopyrimidine derivatives as cdk inhibitors, the production thereof, and use as a medicine
10/06/11Novel aliphatically substituted pyrazolopyridines, and the use thereof
10/06/11Substituted benzyl and phenylsulfonyl triazolones, and use thereof
09/29/11Substituted amido phenoxybenzamides
09/29/11Amino acid ester prodrugs and the use thereof
09/22/11Monospecific and multispecific antibodies and use
09/08/11Substituted sulphonamido phenoxybenzamides
09/08/11G-protein coupled receptor 30 (gpr30) transgenic animals as a model for cardiovascular diseases
08/25/11Heteroaryl-substituted dicyanopyridines and their use
08/25/11Substituted 4-(indazolyl)-1,4-dihydropyridines and methods of use thereof
08/18/11Contrast agent-reinforced radiotherapy having high-output tubes
08/18/11Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment
08/18/11Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereof
08/04/11Estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a-ring
08/04/11Sulfone substituted 2,3-dihydroimidazo [1,2-c] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis
08/04/11Substituted pyridines, and use thereof as gsk3 inhibitors
07/28/113-cyanoalkyl- and 3-hydroxyalkylindoles and use thereof
07/28/11Novel polymorphic forms of methyl carbamate
07/28/11Process for production of radiopharmaceuticals
07/21/11Cylic polyamines for binding phosphatidylserine
07/21/119-alpha estratriene derivatives as er-beta selective ligands for the prevention and treatment of intestinal cancer
07/21/11Diaryl urea for treating heart failure
07/14/11Annellated 4-(indazolyl)-1,4-dihydropyridine derivatives and methods of use thereof
07/14/11Oxazolidinones for the treatment of inflammatory conditions of the gastrointestinal tract
07/07/11Novel [f-18]- labelled l-glutamic acid and l-glutamine derivatives (i), use thereof and their production
07/07/11Substituted furopyrimidines and use thereof
07/07/11Sulphone-substituted quinazoline derivatives as immuno-modulators, their preparation and use as medicaments
06/30/11Solutions for perfusing and preserving organs and tissues
06/16/11Determination of free fractions
06/09/11Compounds and processes for production of radiopharmaceuticals
06/02/11Identification of new splice-variants of g-protein coupled receptor ep3 and uses thereof
Patent Packs
06/02/11Substituted aryloxazoles and their use
06/02/11Process for preparing methyl methylcarbamate and its purification for use as pharmaceutically active compound
06/02/11Process for preparing methyl carbamate and its purification for use as pharmaceutically active compound
06/02/11Substituted 3-phenylpropionic acids and the use thereof
05/26/11Use of radioactively labelled molecule specifically binding to ed-b fibronection in a treatment of hodgkin lymphoma
05/26/11Novel, cyclically substituted furopyrimidine derivatives and use thereof
05/19/111,4-diaryl-pyrimidopyridazine-2,5-diones and their use
05/12/11Ctgf as a biomarker, therapeutic and diagnostic target
05/12/11Purification strategy for direct nucleophilic procedures
05/05/11Novel [f-18]-labelled l-glutamic acid and l-glutamine derivatives (ii), their use and processes for their preparation
05/05/11Dimeric molecular complexes
04/28/11Estradiol-containing drug delivery system
04/21/11Sgc stimulators, sgc activators and combinations thereof for the treatment of hearing impairment
04/14/11Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
03/17/11Aqueous formulations of (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate
Patent Packs
03/10/11Process for the purification of interleukin-4 and its muteins
03/03/11Imidazo-, pyrazolopyrazines and imidazotriazines and their use
02/17/11Novel aza-bicyclic compounds and their use as stimulators of soluble guanylate cyclase
02/10/114-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
02/03/11Anti-mesothelin antibodies and uses thereof
02/03/11Substituted pyrrolotriazines and their use
01/27/11New modulating molecules for an improved regulated expression system
01/27/1117-hydroxy-19-nor-21-carboxylic acid-steroid y-lactone derivative, use thereof, and medicament containing the derivative
01/27/11Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and their use
01/27/11Substituted piperidines
01/27/11Substituted tricyclic compounds and methods of use thereof
01/20/1115,16-methylene-17-hydroxy-19-nor-21-carboxylic acid-steroid y-lactone derivative, use thereof and medicinal products containing the derivative
01/20/11Substituted heterocycles and use thereof
01/20/11Tamper-proof closure having a retaining pin
01/13/112-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
01/06/11Mineralcorticoid receptor antagonists for the treatment of endometriosis
12/16/1017-(1'propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
12/16/10Novel aminodicarboxylic acid derivatives having pharmaceutical properties
12/09/10Spike having two pins
12/02/10Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof
12/02/10Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
11/25/102-phenoxy nicotine acid derivative and use thereof
11/18/10Aminoacyl prodrug derivatives and medicaments for treatment of thromboembolic disorders
10/28/10Aminoacyl prodrugs
10/21/10Methods for the prophylaxis and/or treatment of thromboembolic disorders by combination therapy with substituted oxazolidinones
10/21/10Trisubstituted furopyrimidines and use thereof
10/14/10Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
10/14/10Substituted oxazolidinones and their use
10/14/10Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
Social Network Patent Pack
10/07/10Cell differentiation inducer
09/30/10Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
09/23/103-cyano-5-thiazaheteroaryl-dihydropyridine and the use thereof for the treatment of cardiovascular diseases
08/19/10Sgc stimulators, sgc activators and combinations for the treatment of urological disorders
07/22/10Substituted oxazolidinones and their use
07/22/10Pde inhibitors for the treatment of hearing impairment
07/22/10Heterocyclic derivatives
07/15/10Use of phenyloxyaniline derivatives for imaging cardiovascular diseases
07/15/10Substituted azaquinazolines having an antiviral action
07/01/10Substituted dibenzoic acid derivatives and use thereof
Patent Packs
06/24/104-phenoxy-nicotine acid derivatives and use thereof as ppar-modulators
06/03/10Selection two contrast media for use in a dual-energy ct examination, contrast media combination and generation of ct images using a contrast media combination and different energy spectra
06/03/10Tetrahydro-quinolinylurea derivatives
05/13/10Combination therapy of substituted oxazolidinones
05/06/10Substituted imidazopyrimidines and triazolopyrimidines
05/06/10Polymorph ii of 4-[4-(amino)-3- fluorophenoxy]-n-methylpyridine-2-carboxamide
04/29/10Substituted aminofuranones and their use
04/29/10Substituted 7-sulfanylmethyl-, 7-sulfinylmethyl- and 7-sulfonylmethylindoles and the use thereof
04/22/10Substituted 5-aminopyrazoles and use thereof
04/15/10Novel substituted bipyridine derivatives and their use as adenosine receptor ligands
03/25/10Sulfoximine-substituted pyrimidines as cdk- and/or vegf inhibitors, their production and use as pharmaceutical agents
03/18/10Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof
03/11/10Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1, 3-oxazolines and their use as anticoagulant and antithrombotics
03/11/10Polymorph iii of 4-[4-(amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide
02/25/10Timp-4 as a biomarker for the diagnosis of cardiac insufficiency
02/04/10Indolylamides as modulators of the ep2 receptor
02/04/10Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivatives as stimulators of guanylate cyclase for cardiovascular disorders
01/28/10Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof
01/21/102-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
12/24/09Novel tissue factor targeted antibodies as anticoagulants
11/26/09Dna encoding a novel rg1 polypeptide
10/29/09Substituted dihydropyrazolones and their use
08/27/09Dna encoding a novel rg1 polypeptide
08/20/09Generation of replication competent viruses for therapeutic use
07/02/09Ep2 and ep4 agonists as agents for the treatment of influenza a viral infection
02/05/09Crystalline acid of lipoxin a4 analogs and making
01/28/10Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof
01/21/102-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Bayer Schering Pharma Aktiengesellschaft in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Bayer Schering Pharma Aktiengesellschaft with additional patents listed. Browse our Agent directory for other possible listings. Page by